ウシ胎児血清の世界市場レポート 2024年

ウシ胎児血清の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には8.7%の年間複合成長率（CAGR）で1兆6,440億6,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、細胞療法の採用の増加、先進的な治療法の出現、細胞培養培地の動物を含まない代替品への注目の高まり、サプライヤーと顧客の戦略的な関係の発展などの要因に起因すると考えられます。予測期間中に予想される主要動向としては、細胞培養培地の品質とトレーサビリティへの注目の高まり、バイオ医薬品産業における世界の協力とパートナーシップ、戦略的合併と買収、ウシ胎児血清製品のカスタマイズ、規制遵守と倫理的調達の重視の高まりなどが挙げられます。

予想されるバイオ医薬品の需要の急増は、予測期間におけるウシ胎児血清（FBS）市場の成長の重要な推進力となる準備ができています。バイオ医薬品とは、動物、人間、微生物などの生物源に由来し、その製造にバイオテクノロジーを利用した医薬品です。 ウシ胎児血清は、動物細胞培養培地の代替として最も広く利用されており、このプロセスで重要な役割を果たします。製薬会社、診断ラボ、研究者は、生物製剤調査における細胞培養要件を満たすためにFBSに大きく依存しています。英国に本拠を置くライフサイエンスサービスとコンサルティング会社であるProClinical Limitedは、2022年に医薬品とワクチン部門で3,615万米ドルに達し、前年比11%増となる顕著な売上高を報告しました。この財務実績は、バイオ医薬品関連の製品とサービスに対する需要の高まりを裏付けています。したがって、バイオ医薬品に対するニーズの高まりが、ウシ胎児血清市場の成長を促進する重要な要因となっています。

ワクチン生産の予想される増加は、予測期間におけるウシ胎児血清（FBS）市場の成長の重要な推進力となる準備ができています。特定の感染症に対する能動的な獲得免疫を提供するように設計されたワクチンは、多くの場合、製造プロセスで重要な細胞の増殖をサポートする細胞培養培地としてFBSを利用します。 FBSは、特定の細胞株の培養に必要な必須栄養素、成長因子、ホルモンを提供し、ワクチンの基礎を形成するウイルスや抗原の効率的な複製を促進することで重要な役割を果たします。たとえば、スイスに本拠を置く業界団体である国際製薬工業連盟（IFPMA）のデータによると、2021年9月の時点でワクチンメーカーは月間15億回分のワクチンを生産しており、年末までに120億回分に達すると予測されています。このワクチン生産の急増は、ウシ胎児血清市場の成長を推進する重要な要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界のウシ胎児血清市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のウシ胎児血清市場規模実績と成長、2018～2023年
• 世界のウシ胎児血清市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界のウシ胎児血清市場、製品別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 活性炭処理
• クロマトグラフィー
• 透析ウシ胎児血清
• エクソソーム除去
• 幹細胞
• その他
• 世界のウシ胎児血清市場、用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 創薬
• 細胞培養培地
• 体外受精
• ヒトと動物のワクチンの製造
• 診断
• その他
• 世界のウシ胎児血清市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 研究と学術機関
• バイオテクノロジーと製薬産業
• その他

第7章 地域と国の分析

• 世界のウシ胎児血清市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界のウシ胎児血清市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ウシ胎児血清市場の競合情勢
• ウシ胎児血清市場の企業プロファイル
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GE Healthcare
  • Corning Incorporated
  • Cytiva

第31章 その他の大手と革新的な企業

• VWR International
• Sartorius AG
• Bio-Techne Corporation
• Atlas Biologicals Inc.
• R&D Systems Inc.
• Atlanta Biologicals Inc.
• Cyagen Biosciences
• GenClone Inc.
• Gemini Bio-Products
• Access Biologicals LLC
• Nucleus Biologics
• ZenBio Inc.
• Biowest
• Wellington Laboratories Inc.
• Bovogen Biologicals Pty Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

Fetal bovine serum is a crucial component in animal cell culture media used to support the growth of eukaryotic cells cultured in vitro. It is obtained from bovine fetuses harvested from pregnant cows slated for slaughter, often through a cardiac puncture without anesthesia.

The main types of fetal bovine serum include charcoal-stripped, chromatographic, dialyzed, exosome-depleted, stem cell, and others. Charcoal-stripped fetal bovine serum contains activated carbon that helps reduce levels of lipophilic compounds such as hormones, growth factors, and steroids. It is commonly used in studies related to receptors or estrogen. Dialyzed fetal bovine serum has a reduced concentration of low molecular weight components, such as nucleotides, amino acids, hormones, salts, and small proteins, making it suitable for cell culture systems that require a more defined environment of small molecules. Exosome-depleted fetal bovine serum is designed to isolate exosomes from cultured cells without the presence of bovine exosomes found in conventional fetal bovine serum. This type is often used for research on exosomes. Fetal bovine serum finds applications in various areas, including drug discovery, cell culture media, in vitro fertilization, human and animal vaccine production, diagnostics, and more. The usage of fetal bovine serum spans across different sectors, including research and academic institutes, the biotechnology and pharmaceutical industry, and other related fields.

The fetal bovine serum market research report is one of a series of new reports from The Business Research Company that provides fetal bovine serum market statistics, including fetal bovine serum industry global market size, regional shares, competitors with a fetal bovine serum market share, detailed fetal bovine serum market segments, market trends and opportunities, and any further data you may need to thrive in the fetal bovine serum industry. This fetal bovine serum market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fetal bovine serum market size has grown strongly in recent years. It will grow from $1095.25 billion in 2023 to $1176.47 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth observed in the historical period can be attributed to factors such as the expansion of the biopharmaceutical industry, the increase in cell-based therapies, and the growing emphasis on quality and consistency requirements in the manufacturing processes.

The fetal bovine serum market size is expected to see strong growth in the next few years. It will grow to $1644.06 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The anticipated growth in the forecast period can be attributed to factors such as the increasing adoption of cell therapies, the emergence of advanced therapeutics, a growing focus on animal-free alternatives in cell culture media, and the development of strategic supplier-customer relationships. Major trends expected in the forecast period include an increased focus on quality and traceability in cell culture media, global collaboration and partnerships in the biopharmaceutical industry, strategic mergers and acquisitions, the customization of fetal bovine serum products, and a heightened emphasis on regulatory compliance and ethical sourcing in the production of cell culture media.

The anticipated surge in demand for biopharmaceuticals is poised to be a significant driver for the growth of the fetal bovine serum (FBS) market in the forecast period. Biopharmaceuticals are medicinal products derived from biological sources such as animals, humans, and microorganisms, employing biotechnology in their production. Fetal bovine serum, being the most widely utilized substitute for animal cell culture media, plays a crucial role in this process. Pharmaceutical companies, diagnostic laboratories, and researchers heavily depend on FBS to meet their cell culture requirements in biologics research. In 2022, ProClinical Limited, a UK-based life sciences service and consulting company, reported notable sales in the pharmaceuticals and vaccines segments, amounting to US$36.15 million, reflecting an 11% year-over-year increase. This financial performance underscores the growing demand for products and services related to biopharmaceuticals. Consequently, the escalating need for biopharmaceuticals is a key factor driving the growth of the fetal bovine serum market.

The anticipated increase in vaccine production is poised to be a significant driver for the growth of the fetal bovine serum (FBS) market in the forecast period. Vaccines, designed to provide active, acquired immunity to specific infectious diseases, often utilize FBS as a cell culture medium to support the growth of cells crucial in the manufacturing process. FBS plays a vital role by providing essential nutrients, growth factors, and hormones necessary for cultivating specific cell lines, facilitating efficient replication of the virus or antigen that forms the foundation of the vaccine. For example, as of September 2021, data from the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), a Switzerland-based trade association, indicated that vaccine manufacturers were producing 1.5 billion monthly doses, with projections to reach 12 billion by the end of 2021 and 24 billion by June 2022, potentially surpassing global demand. This surge in vaccine production is a key factor propelling the growth of the fetal bovine serum market.

The fetal bovine serum market is witnessing a prominent trend marked by the growing number of collaborations between companies and research institutions. Major industry players are entering into partnerships to enhance production capabilities, expand market share, and foster the development of innovative products. A case in point is the collaboration between the US-based GE Healthcare and the New Zealand-based Oritain. In this collaboration, GE Healthcare and Oritain are working together to create an independent test capable of confirming the country of origin of fetal bovine serum (FBS). This development is particularly significant for biomanufacturing entities, as FBS sourced from different countries may present varying levels of risk for virus contamination. By establishing a reliable method to verify the origin of FBS, this collaboration aims to provide valuable assistance to biomanufacturing entities in ensuring the safety and quality of FBS used in diverse countries.

Major companies in the fetal bovine serum industry are actively developing and focusing on innovative products, such as USDA-approved fetal bovine serum, to address the requirements of researchers while aligning with budget constraints. These products aim to provide consistent quality and value for basic research applications. USDA-approved fetal bovine serum is designed to meet stringent safety standards established by the United States Department of Agriculture (USDA), ensuring it undergoes testing for the absence of specific diseases. This makes it a reliable option for various research and production applications. An example of such innovation is demonstrated by Thermo Fisher Scientific Inc., a US-based biotechnology company. In August 2021, Thermo Fisher Scientific introduced Gibco Fetal Bovine Serum. This product is a qualified, heat-inactivated, USDA-approved serum suitable for basic cell culture, specialty research, and specific assays. It holds USDA approval in North America and qualification in other regions, including Brazil. The Gibco Fetal Bovine Serum by Thermo Fisher Scientific offers excellent value for research needs and budgets, ensuring consistent quality and backed by award-winning support from Gibco. The product is ISO 13485-certified, processed in FDA-registered facilities, suitable for cell culture with robust cell lines, and has an endotoxin level of = 20 EU/mL. This exemplifies the industry's commitment to providing high-quality, compliant, and versatile solutions for researchers in various regions.

Sartorius, a German-based life science research and biopharmaceutical company acquired Biological Industries for $53.67 million. Through this acquisition, Sartorius expanded cell culture media and complementing the product portfolio for the users in the growing advanced therapies market in the majority portion of Biological Industries. Biological Industries is an Israel-based chemical and biotechnology company that provides fetal bovine serum for mammalian cell culture.

Major companies operating in the fetal bovine serum market report are Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare, Corning Incorporated, Cytiva, VWR International, Sartorius AG, Bio-Techne Corporation, Atlas Biologicals Inc., R&D Systems Inc., Atlanta Biologicals Inc., Cyagen Biosciences, GenClone Inc., Gemini Bio-Products, Access Biologicals LLC, Nucleus Biologics, ZenBio Inc., Biowest, Wellington Laboratories Inc., Bovogen Biologicals Pty Ltd., TCS Biosciences Ltd., J R Scientific Inc., Rocky Mountain Biologicals Inc., Tissue Culture Biologicals, Moregate Biotech, Cell Applications Inc., Altogen Biosystems, Axil Scientific Pte Ltd., Animal Technologies Inc., PAN- Biotech, PAA Laboratories GmbH, Peak Serum Inc., Biochrom GmbH

North America was the largest region in the fetal bovine serum market in 2023. Asia-Pacific recorded the fastest growth during the forecast period. The regions covered in the fetal bovine serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the fetal bovine serum market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fetal bovine serum market consists of sales of Ultra-low IgG, ES Cell, MSC and Exosome-Depleted. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fetal Bovine Serum Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fetal bovine serum market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fetal bovine serum ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fetal bovine serum market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Charcoal Stripped; Chromatographic; Dialyzed Fetal Bovine Serum; Exosome Depleted; Stem Cell; Other Products
• 2) By Application: Drug Discovery; Cell Culture Media; In Vitro Fertilization; Human and Animal Vaccine Production; Diagnostics; Other Applications
• 3) By End-User: Research and Academic Institutes; Biotechnology and Pharmaceutical Industry; Other End-Users
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; GE Healthcare; Corning Incorporated; Cytiva
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Fetal Bovine Serum Market Characteristics

3. Fetal Bovine Serum Market Trends And Strategies

4. Fetal Bovine Serum Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Fetal Bovine Serum Market Size and Growth

• 5.1. Global Fetal Bovine Serum Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Fetal Bovine Serum Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Fetal Bovine Serum Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Fetal Bovine Serum Market Segmentation

• 6.1. Global Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Charcoal Stripped
• Chromatographic
• Dialyzed Fetal Bovine Serum
• Exosome Depleted
• Stem Cell
• Other Products
• 6.2. Global Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Drug Discovery
• Cell Culture Media
• In Vitro Fertilization
• Human and Animal Vaccine Production
• Diagnostics
• Other Applications
• 6.3. Global Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Research and Academic Institutes
• Biotechnology and Pharmaceutical Industry
• Other End-Users

7. Fetal Bovine Serum Market Regional And Country Analysis

• 7.1. Global Fetal Bovine Serum Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Fetal Bovine Serum Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Fetal Bovine Serum Market

• 8.1. Asia-Pacific Fetal Bovine Serum Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Fetal Bovine Serum Market

• 9.1. China Fetal Bovine Serum Market Overview
• 9.2. China Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Fetal Bovine Serum Market

• 10.1. India Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Fetal Bovine Serum Market

• 11.1. Japan Fetal Bovine Serum Market Overview
• 11.2. Japan Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Fetal Bovine Serum Market

• 12.1. Australia Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Fetal Bovine Serum Market

• 13.1. Indonesia Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Fetal Bovine Serum Market

• 14.1. South Korea Fetal Bovine Serum Market Overview
• 14.2. South Korea Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Fetal Bovine Serum Market

• 15.1. Western Europe Fetal Bovine Serum Market Overview
• 15.2. Western Europe Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Fetal Bovine Serum Market

• 16.1. UK Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Fetal Bovine Serum Market

• 17.1. Germany Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Fetal Bovine Serum Market

• 18.1. France Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Fetal Bovine Serum Market

• 19.1. Italy Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Fetal Bovine Serum Market

• 20.1. Spain Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Fetal Bovine Serum Market

• 21.1. Eastern Europe Fetal Bovine Serum Market Overview
• 21.2. Eastern Europe Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Fetal Bovine Serum Market

• 22.1. Russia Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Fetal Bovine Serum Market

• 23.1. North America Fetal Bovine Serum Market Overview
• 23.2. North America Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Fetal Bovine Serum Market

• 24.1. USA Fetal Bovine Serum Market Overview
• 24.2. USA Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Fetal Bovine Serum Market

• 25.1. Canada Fetal Bovine Serum Market Overview
• 25.2. Canada Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Fetal Bovine Serum Market

• 26.1. South America Fetal Bovine Serum Market Overview
• 26.2. South America Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Fetal Bovine Serum Market

• 27.1. Brazil Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Fetal Bovine Serum Market

• 28.1. Middle East Fetal Bovine Serum Market Overview
• 28.2. Middle East Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Fetal Bovine Serum Market

• 29.1. Africa Fetal Bovine Serum Market Overview
• 29.2. Africa Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Fetal Bovine Serum Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Fetal Bovine Serum Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Fetal Bovine Serum Market Competitive Landscape And Company Profiles

• 30.1. Fetal Bovine Serum Market Competitive Landscape
• 30.2. Fetal Bovine Serum Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Merck KGaA
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. GE Healthcare
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Corning Incorporated
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Cytiva
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Fetal Bovine Serum Market Other Major And Innovative Companies

• 31.1. VWR International
• 31.2. Sartorius AG
• 31.3. Bio-Techne Corporation
• 31.4. Atlas Biologicals Inc.
• 31.5. R&D Systems Inc.
• 31.6. Atlanta Biologicals Inc.
• 31.7. Cyagen Biosciences
• 31.8. GenClone Inc.
• 31.9. Gemini Bio-Products
• 31.10. Access Biologicals LLC
• 31.11. Nucleus Biologics
• 31.12. ZenBio Inc.
• 31.13. Biowest
• 31.14. Wellington Laboratories Inc.
• 31.15. Bovogen Biologicals Pty Ltd.

32. Global Fetal Bovine Serum Market Competitive Benchmarking

33. Global Fetal Bovine Serum Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Fetal Bovine Serum Market

35. Fetal Bovine Serum Market Future Outlook and Potential Analysis

• 35.1 Fetal Bovine Serum Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Fetal Bovine Serum Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Fetal Bovine Serum Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer